Neutrophil precursor generation: Effects of culture conditions

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 5, 1998, Pages 463-471

  Martinson, Jeffrey A ^a   Unverzagt, Kristen ^a   Schaeffer, Andrew ^b   Smith, Stephen L ^a   Loudovaris, Maureen ^b   Schneidkraut, Marlowe J ^a   Bender, James G ^b   Van Epps, Dennis E ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Nexell Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 3; INTERLEUKIN 6; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING CELL; CULTURE MEDIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NEUTROPHIL; PRIORITY JOURNAL; STEM CELL;

EID: 0031737869     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1998.7.463     Document Type: Article

References (41)

1. Berenson, R.J., Bensinger, W.I., Hill, R.S., et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77:171, 1991.
2. Bensinger, W.I., Berenson, R.J., Andrews, R.G., et al. Engraftment after infusion of CD34 enriched marrow cells. Int. J. Cell Cloning 10 (Suppl. 1): 176, 1992.
3. Kessinger, A., & Armitage, J.O. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [Editorial]. Blood 77:211, 1991.
4. Gianni, A.M., Siena, S., Bregni, M., et al. The use of GM-CSF and peripheral blood stem cells (PBSC) minimizes haematological toxicity following a myeloablative course of chemo-radiotherapy. Pathol. Biol. 39:956, 1992.
5. Zander, A.R., Lyding, J., & Bielack, S. Transplantation with blood stem cells. Blood Cells 17:301, 1991.
6. Bensinger, W.I., Longin, K., Appelbaum, F., et al. Peripheral blood stem cells (PBSCs) collected after granulocyte colony-stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87:825, 1994.
7. Weaver, C.H., Hazelton, B., Birch, R., et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961, 1995.
8. Schiller, G., Vescio, R., Freytes, C., et al. Transplantation of CD34+ peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995.
9. Brugger, W., Henschler, R., Heimfeld, S., et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoieic engraftment after high dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994.
10. Brugger, W., Birken, R., Bertz, H., et al. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin. Br. J. Haematol. 84:402, 1993.
11. Bensinger, W., Singer, J., Appelbaum, K., et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993.
12. To, L.B., Roberts, M.M., Haylock, D.N., et al. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant. 9:277, 1992.
13. Tricot, G., Jagannath, S., Vesole, D., et al. Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588, 1995.
14. Brugger, W., Heimfeld, S., Berenson, R.J., et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 333:283, 1995.
15. Williams, S.F., Lee, W.J., Bender, J.G., et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 87:1687, 1996.
16. Cairo, M. Hematopoietic growth factors: A new frontier in immunotherapy. J. Pediatr. 118, S1, 1991.
17. Gauwerky, C.E., & Golde, D.W. Hematopoietic stem cells and their growth factors. Klin. Wochenschr. 61:975, 1983.
18. Zimmerman, T., Bender, J.G., Lee, W.J., et al. Large-scale selection of CD34+ peripheral blood progenitors and expansion of neutrophil precursors for clinical applications. J. Hematother. 5:247, 1996.
19. Lill, M.C., Lynch, M., Fraser, J.K., et al. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system. Stem Cells 12:626, 1994.
20. Haylock, D.N., To, L.B., Dowse, T.L., et al. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 80:1405, 1992.
21. Smith, S.L., Bender, J.G., Maples, P.B., et al. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. Exp. Haematol. 21:870, 1993.
22. Takaue, Y., Kawano, Y., Reading, C.L., et al. Effects of recombinant human G-CSF, GM-CSF, IL-3, and IL-1 alpha on the growth of purified human peripheral blood progenitors. Blood 76:330, 1990.
23. Brugger, W., Mocklin, W., Heimfeld, S., et al. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 81: 2579, 1993.
24. To, L.B., Haylock, D.N., Dowe, T., et al. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood 84:2930, 1994.
25. McKenna, H.J., de Vries, P., Brasel, K., et al. Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells. Blood 86:3413, 1995.
26. Sato, N., Sawada, K., Koizumi, K., et al. In vitro expansion of human peripheral blood CD34+ cells. Blood 82:3600, 1993.
27. Koizumi, K., Sawada, K., Sato, N., et al. Transitional changes in immunophenotypic subpopulations of human peripheral blood CD34+ cells expanded in vitro. Exp. Hematol. 22:1171, 1994.
28. Johnsen, H.E., Jensen, L., Gaarsdal, E., et al. Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures. Exp. Hematol. 22:80, 1994.
29. Ichihara, M., Hotta, T., Asano, H., et al. Effects of stem cell factor (SCF) on human marrow neutrophil, neutrophil/macrophage mixed, macrophage and eosinophil progenitor cell growth. Int. J. Hematol. 59:81, 1994.
30. Makino, S., Haylock, D., Dowse, T., et al. Ex vivo culture of peripheral blood CD34+ cells: Effects of hematopoietic growth factors on production of neutrophilic precursors. J. Hematother. 6:475, 1997.
31. Saeland, S., Caux, C., Favre, C., et al. Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood 72:1580, 1988.
32. Saeland, S., Caux, C., Favre, C., et al. Combined and sequential effects of human IL-3 and GM-CSF on the proliferation of CD34+ hematopoietic cells from cord blood. Blood 73:1195, 1989.
33. Serke, S., Sauberlich, S., & Huhn, D. A liquid culture method for the in vitro growth of hematopoietic progenitor cells from normal human adult peripheral blood allowing for analysis by multiparameter flow-cytometry. Eur. J. Haematol. 46:85, 1991.
34. Frenk, R.W., Ventura, G.J., Krannig, G., et al. Studies of the function and structure of in vitro propagated human granulocytes. Pediatr. Res. 30:135, 1991.
35. Bender, J.G. & Unverzagt, K. Flow cytometric analysis of peripheral blood stem cells. J. Hematother. 2:421, 1993.
36. Smith, S.L., Bender, J.G., Maples, P.B., et al. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. Exp. Hematol. 21:870, 1993.
37. Nicola, N.A., & Metcalf, D. Specificity of action of colony-stimulating factors in the differentiation of granulocytes and macrophages. Ciba Found. Symp. 118:7, 1986.
38. Souza, L.M., Boone, T.C., Gabrilove, J., et al. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Sceince 232:61, 1986.
39. Mendoza, J.F., Caceres, R., Santiago, E., et al. Evidence that G-CSF is a fibroblast growth factor that induces granulocytes to increase phagocytosis and to present a mature morphology, and that macrophages secrete 45-kd molecules with these activities as well as with G-CSF like activity. Exp. Hematol. 18:903, 1990.
40. Fukunaga, R., Ishizaka-Ikeda, E., & Nagata, S. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 74:1079, 1993.
41. Chang, Q., Hanks, S., Akard, L., et al. Maturation of mobilized peripheral blood progenitor cells: Preclinical and phase I clinical studies. J. Hematother. 4:289, 1995.